Jose B, Friedman S R, Neaigus A, Curtis R, Grund J P, Goldstein M F, Ward T P, Des Jarlais D C
National Development and Research Institutes, Inc., New York, New York 10013.
AIDS. 1993 Dec;7(12):1653-60. doi: 10.1097/00002030-199312000-00017.
In syringe-mediated drug-sharing (backloading), injecting drug users (IDU) use their syringes to mix drugs and to give measured shares to other IDU by squirting drug solution into the syringes of other IDU. Backloading has been discussed as a potential HIV risk factor, but its role as an HIV transmission route has not been established empirically.
Six hundred and sixty IDU who had injected drugs in the previous 2 years were street-recruited from Bushwick, New York City through chain referral, tested for HIV antibody and interviewed about sexual and drug-risk behaviors.
Receiving drugs via backloading in the previous 2 years was reported by 24.5% of the subjects. These subjects had significantly higher HIV seroprevalence than those who did not receive drugs by backloading (odds ratio, 2.2; 95% confidence interval, 1.5-3.1). Backloading remained positively and significantly associated with HIV seropositivity in stepwise logistic regression, and in a series of simultaneous logistic models controlling for sociodemographic variables and for sexual and drug risk variables.
Backloading can be a route of HIV transmission among IDU and should be incorporated into risk-factor studies and HIV transmission modeling. Many IDU who avoid other high-risk drug-injection practices may overlook the risk of backloading. HIV prevention programs should warn IDU against syringe-mediated drug-sharing and work together to develop ways to avoid it.
在注射器介导的药物共享(回注法)中,注射吸毒者(IDU)使用他们的注射器混合毒品,并通过将毒品溶液注入其他IDU的注射器中,给其他IDU提供定量的毒品份额。回注法已被作为一种潜在的HIV风险因素进行讨论,但其作为HIV传播途径的作用尚未得到实证确定。
通过连锁推荐从纽约市布什wick区街头招募了660名在过去2年中注射过毒品的IDU,检测HIV抗体,并就性和毒品风险行为进行访谈。
24.5%的受试者报告在过去2年中通过回注法接受过毒品。这些受试者的HIV血清阳性率显著高于那些未通过回注法接受毒品的受试者(优势比,2.2;95%置信区间,1.5 - 3.1)。在逐步逻辑回归以及一系列控制社会人口统计学变量和性与毒品风险变量的同时逻辑模型中,回注法与HIV血清阳性仍呈显著正相关。
回注法可能是IDU之间HIV传播的一种途径,应纳入风险因素研究和HIV传播模型。许多避免其他高风险吸毒注射行为的IDU可能忽视了回注法的风险。HIV预防项目应警告IDU防范注射器介导的药物共享,并共同努力开发避免这种情况的方法。